Cue Biopharma Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
CUE Nasdaq 8731 https://www.cuebiopharma.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cue Biopharma Inc

Cue Biopharma to Present at the JMP Securities Hematology and Oncology Summit - Nov 22nd, 2023 1:00 pm
Cue Biopharma, Inc. (NASDAQ:CUE) Q3 2023 Earnings Call Transcript - Nov 12th, 2023 5:55 pm
Cue Biopharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights - Nov 9th, 2023 9:05 pm
Cue Biopharma to Present at Three Upcoming Investor Healthcare Conferences in November - Nov 7th, 2023 1:00 pm
Cue Biopharma Presents New Positive Data from Phase 1 Trials of CUE-101 in Head and Neck Cancer and CUE-102 in Wilms’ Tumor 1 Positive Cancers at SITC 2023 - Nov 3rd, 2023 4:00 pm
Cue Biopharma to Host Business Update Call and Webcast - Nov 2nd, 2023 12:00 pm
Acadia (ACAD) Surges 8.3%: Is This an Indication of Further Gains? - Sep 28th, 2023 9:39 am
Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting - Sep 27th, 2023 1:05 pm
Cue Biopharma Announces Completion of Patient Enrollment in Phase 1b Study of CUE-101 in Combination with KEYTRUDA® - Sep 26th, 2023 12:00 pm
Q2 2023 Cue Biopharma Inc Earnings Call - Aug 10th, 2023 2:37 pm
Cue Biopharma, Inc. (NASDAQ:CUE) Q2 2023 Earnings Call Transcript - Aug 10th, 2023 2:19 pm
Investors in Cue Biopharma (NASDAQ:CUE) have unfortunately lost 83% over the last three years - Aug 10th, 2023 12:28 pm
Cue Biopharma Reports Second Quarter 2023 Financial Results and Recent Business Highlights - Aug 9th, 2023 8:10 pm
3 Biotech Stocks to Buy as Companies Ink Major Deals - Jun 22nd, 2023 10:40 am
Cue Biopharma to Present at the Federation of Clinical Immunology Societies (FOCIS) 2023 Annual Meeting - Jun 14th, 2023 12:00 pm
Cue Biopharma to Host Investor Call - Jun 7th, 2023 12:00 pm
Cue Biopharma to Present at the Jefferies 2023 Global Healthcare Conference - Jun 5th, 2023 12:00 pm
3 Biotech Stocks Sitting on Huge-Upside Catalysts - May 26th, 2023 10:19 am
Cue Biopharma Presents Positive Data Update from Ongoing Phase 1 Trials of CUE-101 for Recurrent/Metastatic HPV+ Head and Neck Squamous Cell Carcinoma at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting - May 25th, 2023 9:00 pm
Cue Biopharma to Present at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting - May 15th, 2023 12:00 pm